Real-World study tests Once-Daily pill for ulcerative colitis in chinese adults
NCT ID NCT07705126
First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time
Summary
This study looks at how the oral medication etrasimod works for Chinese adults with active ulcerative colitis (UC) in real-world settings. About 500 participants will take etrasimod as part of their routine care and be followed for at least 52 weeks. Researchers will track changes in UC symptoms, disease flares, treatment adjustments, and safety. The goal is to understand how etrasimod performs outside of controlled clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- etrasimod, an oral medication taken once daily that reduces gut inflammation
- What this could lead to
- If successful, this study could show that etrasimod is effective and safe for Chinese adults with active ulcerative colitis in everyday clinical practice, potentially expanding treatment options.
- What could go wrong
- This is an observational registry, not a controlled trial, so results may be influenced by patient differences and real-world variability. It also focuses only on Chinese adults, so findings may not apply to other populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tangdu Hospital
Xi’an, Shanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Stool test may predict gut healing in ulcerative colitis
- New staining technique could sharpen healing assessment in IBD
- Can a higher dose of upadacitinib rescue ulcerative colitis patients when standard treatment fails?
- Study aims to keep workers with chronic illnesses on the job
- Real-World study tests Mirikizumab's power against ulcerative colitis
- New oral drug INT-210 aims to tame ulcerative colitis Flare-Ups